Al Lin - Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC) @ FibroGen

Overview

CB Rank (Person)

Primary Job Title Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC)
Primary Organization
FibroGen

Gender Male

Al Lin is the Vice President of preclinical development and chemical manufacturing and control at FibroGen, a research-based biotech firm that uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

Jobs

Number of Current Jobs

Al Lin

is the

Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC)

FibroGen

FibroGen Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC)

Related Hubs

Hub Name	CB Rank (Hub)
Therapeutics Public Companies With More Than $10M in Revenue	38,976
Brookside Capital Portfolio Companies	84,580
PaineWebber Alumni Founded Companies	88,517
Adage Capital Management Portfolio Companies	57,239
Hony Capital Portfolio Companies	62,215
Biopharma Public Companies With More Than $1M in Revenue	30,850
AstraZeneca Portfolio Companies	89,455
Biopharma Public Companies With More Than $10M in Revenue	33,409

Recent News and Activity

There is no recent news or activity for this profile.